In Review: A Senate bill that includes a dispensing fee and ERISA was scheduled for a hearing this week, but was pulled from the agenda the day before. We anticipate that the bill will be scheduled for a hearing at
Up Next: PCMA will host a Zoom call this Wednesday to begin preparing for DOI’s rulemaking implementing HB 596 (ban on spread pricing, 100% pass-through, “reasonable” dispensing fees, PBM reporting, and transparency). The new law goes into effect January 1,
Up Next: We are working on putting together a regulatory workgroup to coordinate and engage with DOI as they develop regulations to implement HB 596. If you have any questions, please contact Bill Head at bhead@pcmanet.org.
In Review: HB 596 (ban on spread pricing, mandatory minimum pharmacy reimbursement, transparency, 100% pass-through, mail order, and white bagging), as amended by the Senate and passed in the House by a vote of 53-15 on Tuesday, March 26 and sent
In Review: House Bill 596 (ban on spread, mandatory minimum pharmacy reimbursement, transparency, 100% pass-through, mail order, and white bagging) was concurred to by the House Health and Welfare Committee and is now headed to the House floor for final passage.
In Review: PCMA member company representatives met with health plans in Boise last week to create a single proposed amendment document to HB 596 (ban on spread pricing, mandatory minimum pharmacy reimbursement, transparency, 100% pass-through, mail order, and white bagging). The
In Review: SB 1389 (ban on spread pricing, dispensing fees, transparency, white bagging, mail order), the companion bill to HB 596, passed unanimously out the Senate Health & Social Services Committee last week. The team on the ground is coordinating with
In Review: HB 596 (ban on spread, transparency, 100% pass-through, reimbursement, white bagging) passed out of committee on a 7-5 vote with several legislators questioning the need and consequences of the bill. LuGina Mendez-Harper from Prime Therapeutics testified in opposition along
Up Next: We expect Representative Jordan Redman’s (R) PBM bill to be introduced this week. While we anticipate Rep. Redman’s willingness to continue to consider amendments, we expect the bill to be the pharmacists’ version when it is introduced. This could
In Review: LuGina Mendez-Harper (Prime Therapeutics) and Bill Head met with several legislators in Boise last week, including the two primary expected bill sponsors of the anti-BPM legislation, Senator Kevin Cook (R) and Representative Jordan Redman (R). At their request,
